Both of the tandem dual-specific CAR T cells had higher in vitro cytotoxicity compared to monospecific anti-BCMA and anti-TACI L-H CAR T cells against wildtype multiple myeloma cell lines MM1S and RPMI-8226 (Fig. 6a, b). The gene discussed is TNFRSF13B; the disease is plasma cell myeloma.